Ernexa Therapeutics Inc. (ERNA)

Ernexa Therapeutics Statistics

Total Valuation

ERNA has a market cap or net worth of $9.97 million. The enterprise value is $6.75 million.

Market Cap	9.97M
Enterprise Value	6.75M

Important Dates

The last earnings date was Wednesday, August 13, 2025, after market close.

Earnings Date	Aug 13, 2025
Ex-Dividend Date	n/a

Share Statistics

ERNA has 7.67 million shares outstanding. The number of shares has increased by 704.66% in one year.

Current Share Class	7.67M
Shares Outstanding	7.67M
Shares Change (YoY)	+704.66%
Shares Change (QoQ)	+45.58%
Owned by Insiders (%)	53.44%
Owned by Institutions (%)	1.78%
Float	3.16M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	8.12
Forward PS	n/a
PB Ratio	2.30
P/TBV Ratio	4.36
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	13.83
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.81, with a Debt / Equity ratio of 0.13.

Current Ratio	1.81
Quick Ratio	1.69
Debt / Equity	0.13
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-2.33

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-27.19%
Return on Invested Capital (ROIC)	-32.16%
Return on Capital Employed (ROCE)	-238.46%
Revenue Per Employee	$81,333
Profits Per Employee	-$7.29M
Employee Count	6
Asset Turnover	0.02
Inventory Turnover	n/a

Taxes

In the past 12 months, ERNA has paid $34,000 in taxes.

Income Tax	34,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -95.03% in the last 52 weeks. The beta is 6.74, so ERNA's price volatility has been higher than the market average.

Beta (5Y)	6.74
52-Week Price Change	-95.03%
50-Day Moving Average	1.74
200-Day Moving Average	3.74
Relative Strength Index (RSI)	29.53
Average Volume (20 Days)	40,419

Short Selling Information

The latest short interest is 49,468, so 0.64% of the outstanding shares have been sold short.

Short Interest	49,468
Short Previous Month	66,220
Short % of Shares Out	0.64%
Short % of Float	1.57%
Short Ratio (days to cover)	0.62

Income Statement

In the last 12 months, ERNA had revenue of $488,000 and -$43.72 million in losses. Loss per share was -$15.05.

Revenue	488,000
Gross Profit	548,000
Operating Income	-11.76M
Pretax Income	-22.90M
Net Income	-43.72M
EBITDA	-11.67M
EBIT	-11.76M
Loss Per Share	-$15.05

Balance Sheet

The company has $4.32 million in cash and $593,000 in debt, giving a net cash position of $3.72 million or $0.49 per share.

Cash & Cash Equivalents	4.32M
Total Debt	593,000
Net Cash	3.72M
Net Cash Per Share	$0.49
Equity (Book Value)	4.44M
Book Value Per Share	0.59
Working Capital	2.14M

Cash Flow

In the last 12 months, operating cash flow was -$14.43 million and capital expenditures -$19,000, giving a free cash flow of -$14.45 million.

Operating Cash Flow	-14.43M
Capital Expenditures	-19,000
Free Cash Flow	-14.45M
FCF Per Share	-$1.88

Margins

Gross Margin	112.30%
Operating Margin	-2,410.45%
Pretax Margin	-8,948.77%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

ERNA does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-704.66%
Shareholder Yield	-704.66%
Earnings Yield	-417.54%
FCF Yield	-137.97%

Analyst Forecast

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on June 12, 2025. It was a reverse split with a ratio of 1:15.

Last Split Date	Jun 12, 2025
Split Type	Reverse
Split Ratio	1:15

Scores

ERNA has an Altman Z-Score of -46.65 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-46.65
Piotroski F-Score	4